Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer

NCT06476639 is registered in ClinicalTrials.gov with Queensland Centre for Gynaecological Cancer as lead sponsor.

NCT NCT06476639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06476639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer
Lead sponsor
Queensland Centre for Gynaecological Cancer
Phase
Phase 3
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 31, 2035
Enrollment
640 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

groin node, lymph node metastasis, ultrasound therapy; complications, vulvar cancer stage i, vulvar cancer stage ii